advanced search

Ophthalmic Drug Delivery63

Issue No #63  January 27th, 2016


Download PDF


Inside the magazine

A TOPICAL OCULAR RING DESIGNED TO REPLACE GLAUCOMA EYE DROPS
OCULAR
Anne Brody Rubin
A TOPICAL OCULAR RING DESIGNED TO REPLACE GLAUCOMA EYE DROPS
Anne Brody Rubin introduces ForSight VISION5's ring-shaped ocular insert containing prostaglandin for the lowering of intra-ocular pressure in glaucoma.
OPSISPORIN: A LONG-ACTING DRUG DELIVERY APPROACH FOR UVEITIS
OCULAR
Dr Paul Seaman
Midatech Pharma
OPSISPORIN: A LONG-ACTING DRUG DELIVERY APPROACH FOR UVEITIS
Here, Paul Seaman and Daniel Palmer discuss Midatech Pharma’s next generation treatments for auto-immune ocular diseases, which use a combination of innovative, sustained-release drug products.
NEW SOLUTIONS FOR OPHTHALMIC DRUG DELIVERY USING BIODEGRADABLE SILICA MATRIX
OCULAR
Dr Mika Jokinen
DelSiTech Ltd
NEW SOLUTIONS FOR OPHTHALMIC DRUG DELIVERY USING BIODEGRADABLE SILICA MATRIX
Mika Jokinen, Cora Griffin, and Lasse Leino, PhD describe the novel opportunities that biodegradable silica matrix technology offers to ophthalmic drug delivery.
IMPROVING OPHTHALMIC DRUG DELIVERY WITH NOVEL EMULSION TECHNOLOGIES
OCULAR
Robin de Bruijn
EmulTech
IMPROVING OPHTHALMIC DRUG DELIVERY WITH NOVEL EMULSION TECHNOLOGIES
Robin de Bruijn and Frank de Jong describe EmulTech’s ET4ME micro-encapsulation process, and its suitability as a particle formation technology for enhancing and enabling ophthalmic injectables.
USING INTELLIGENT DESIGN TO DELIVER SAFE MULTI-DOSE EYE DROPS
OCULAR
Fanny Sellier
Nemera
USING INTELLIGENT DESIGN TO DELIVER SAFE MULTI-DOSE EYE DROPS
Ms Fanny Sellier, explains how the intelligent design of multi-dose bottles provides a viable means of delivering safe, preservative-free eye drops.
SUSTAINED-RELEASE OCULAR DELIVERY TECHNOLOGIES
EXPERT VIEW
Michael O'Rourke
SUSTAINED-RELEASE OCULAR DELIVERY TECHNOLOGIES
Michael O'Rourke discusses the advances in the development and launching of sustained-release ocular drug delivery systems seen in recent years.
SCALEABILITY OF MICRO INTRAOCULAR IMPLANTS AND DEVICES
OCULAR
Donna Bibber
Micro Engineering Solutions
SCALEABILITY OF MICRO INTRAOCULAR IMPLANTS AND DEVICES
Donna Bibber discusses some of these micro-intraocular implants and devices and the scalability challenges associated with each, from the perspective of a plastics engineer.
THERAPY WITHOUT DROPS: A REALITY
OCULAR
Chris Muller
Mati Therapeutics
THERAPY WITHOUT DROPS: A REALITY
Chris Muller and Deepank Utkhede introduce Mati Therapeutics' Evolute® ocular delivery system, a non-invasive, sustained-release platform that combines a novel punctal plug with a sustained release drug eluting core.
INTRODUCING OCUSURF™ NANOSTRUCTURED EMULSION AS A 505(B)(2) STRATEGY
OCULAR
Dr Shikha P Barman
Integral BioSystems
INTRODUCING OCUSURF™ NANOSTRUCTURED EMULSION AS A 505(B)(2) STRATEGY
Shikha P Barman describes how Integral Biosystems is developing a series of ophthalmic products with its OcuSurf platform.
Top

W3 Total Cache is currently running in Pro version Development mode.